Duke Spotlight: Office for Translation & Commercialization Turns Smart Ideas into Reality
At its core, the Office for Translation & Commercialization is designed to help Duke’s creative minds get the most out of their ideas.
Synthetic Antibiotic Could Be Effective Against Drug-Resistant Superbugs
Decades of work by a series of Duke investigators yields new drug, patents and a startup company Valanbio Therapeutics
Clinetic Announces Series A Funding Round Led by Sopris Capital
Clinetic is a medical records Duke start-up founded on technology developed by a team at the Duke Institute for Health Innovation
Newly Identified Lipid in Breast Milk Might Reduce Cerebral Palsy in Infants
Tellus Therapeutics, a neonatal white matter injury therapeutics start-up, was co-founded by Dr. Eric Brenner (Pediatrics, SOM)
Exploring Entrepreneurship and Social Impact as a New Venture Fellow
Recent Duke Fuqua graduate Lily Schoen reflects on her experience, including working as a New Venture Fellow with Duke OTC
Minutia, Oregon Health & Sciences University and Go Pen Win First-Ever American Diabetes Association Innovation Challenge
Minutia is a next generation cell therapy start-up co-founded by cell sensing luminary Professor Tuan Vo-Dinh (BME, Pratt).
Realtime Robotics Funded an Additional $9.5 Million to Meet Increased Demand for Technology that Transforms Manufacturing
Realtime Robotics, a Duke start-up and Duke Capital Partners portfolio company, was founded by Professor Daniel Sorin (ECE, Pratt).
How a Duke Professor and Two Duke Ph.D.s are Building an AI Drug Discovery Start-Up
Duke Professor Bruce Donald and his former students are combining computer science, structural biology, and an entrepreneurial spirit to design new drugs at Ten63 Therapeutics.
Solve Therapeutics, Inc. Acquires Cereius, Inc., a Duke University Spin-Out
Cereius, a Duke start-up co-founded by Professor Michael Zalutsky (Radiology, SOM) and Dr. Kimberly Blackwell (Adjunct Professor, SOM), has been acquired by Solve Therapeutics.